Incidence of utilization- and symptom-defined COPD exacerbations in hospital- and population-recruited patients

References

• DonaldsonGCSeemungalTABhowmikAWedzichaJARelationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary diseaseThorax2002571084785212324669
   PubMed Web of Science ®Google Scholar
• SullivanSDRamseySDLeeTAThe economic burden of COPDChest20001172 suppl5S9S10673466
   PubMed Web of Science ®Google Scholar
• HalpinDMDecramerMCelliBKestenSLiuDTashkinDPExacerbation frequency and course of COPDInt J Chron Obstruct Pulmon Dis2012765366123055714
   PubMed Web of Science ®Google Scholar
• SeemungalTADonaldsonGCPaulEABestallJCJeffriesDJWedzichaJAEffect of exacerbation on quality of life in patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med19981575 pt 1141814229603117
   PubMed Web of Science ®Google Scholar
• BowlerRPKimVReganECOPDGene InvestigatorsPrediction of acute respiratory disease in current and former smokers with and without COPDChest2014146494195024945159
   PubMed Web of Science ®Google Scholar
• JenkinsCRCelliBAndersonJASeasonality and determinants of moderate and severe COPD exacerbations in the TORCH studyEur Respir J2012391384521737561
   PubMed Web of Science ®Google Scholar
• HusebøGRBakkePSAanerudMPredictors of exacerbations in chronic obstructive pulmonary disease – results from the Bergen COPD cohort studyPLoS One2014910e10972125279458
   PubMed Web of Science ®Google Scholar
• SuzukiMMakitaHItoYMHokkaido COPD Cohort Study InvestigatorsClinical features and determinants of COPD exacerbation in the Hokkaido COPD cohort studyEur Respir J20144351289129724232696
   PubMed Web of Science ®Google Scholar
• TanWCBourbeauJHernandezPCanCOLD Collaborative Research GroupExacerbation-like respiratory symptoms in individuals without chronic obstructive pulmonary disease: results from a population-based studyThorax201469870971724706040
   PubMed Web of Science ®Google Scholar
• NiewoehnerDELokhnyginaYRiceKRisk indexes for exacerbations and hospitalizations due to COPDChest20071311202817218552
   PubMed Web of Science ®Google Scholar
• MiravitllesMGuerreroTMayordomoCFactors associated with increased risk of exacerbation and hospital admission in a cohort of ambulatory COPD patients: a multiple logistic regression analysis. The EOLO Study GroupRespiration200067549550111070451
   PubMed Web of Science ®Google Scholar
• BeehKMGlaabTStowasserSCharacterisation of exacerbation risk and exacerbator phenotypes in the POET-COPD trialRespir Res20131411624168767
   PubMed Web of Science ®Google Scholar
• MüllerovaHMaselliDJLocantoreNECLIPSE InvestigatorsHospitalized exacerbations of COPD: risk factors and outcomes in the ECLIPSE cohortChest20151474999100725356881
   PubMed Web of Science ®Google Scholar
• HurstJRVestboJAnzuetoAEvaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) InvestigatorsSusceptibility to exacerbation in chronic obstructive pulmonary diseaseN Engl J Med2010363121128113820843247
   PubMed Web of Science ®Google Scholar
• de OcaMMTálamoCHalbertRJFrequency of self-reported COPD exacerbation and airflow obstruction in five Latin American cities: the Proyecto Latinoamericano de Investigacion en Obstruccion Pulmonar (PLATINO) studyChest20091361717819349388
   PubMed Web of Science ®Google Scholar
• OzyilmazEKokturkNTeksutGTatliciogluTUnsuspected risk factors of frequent exacerbations requiring hospital admission in chronic obstructive pulmonary diseaseInt J Clin Pract201367769169723758448
   PubMed Web of Science ®Google Scholar
• GroenewegenKHPostmaDSHopWCCOSMIC Study GroupIncreased systemic inflammation is a risk factor for COPD exacerbationsChest2008133235035718198263
   PubMed Web of Science ®Google Scholar
• EaganTMUelandTWagnerPDSystemic inflammatory markers in COPD: results from the Bergen COPD Cohort StudyEur Respir J201035354054819643942
   PubMed Web of Science ®Google Scholar
• ThomsenMIngebrigtsenTSMarottJLInflammatory biomarkers and exacerbations in chronic obstructive pulmonary diseaseJAMA2013309222353236123757083
   PubMed Web of Science ®Google Scholar
• TufvessonEEkbergMBjermerLInflammatory biomarkers in sputum predict COPD exacerbationsLung2013191441341623689877
   PubMed Web of Science ®Google Scholar
• SakaeTMPizzichiniMMTeixeiraPJSilvaRMTrevisolDJPizzichiniEExacerbations of COPD and symptoms of gastroesophageal reflux: a systematic review and meta-analysisJ Bras Pneumol201339325927123857694
   PubMed Web of Science ®Google Scholar
• TeradaKMuroSSatoSImpact of gastro-oesophageal reflux disease symptoms on COPD exacerbationThorax2008631195195518535116
   PubMed Web of Science ®Google Scholar
• QuintJKBaghai-RavaryRDonaldsonGCWedzichaJARelationship between depression and exacerbations in COPDEur Respir J2008321536018321938
   PubMed Web of Science ®Google Scholar
• LaurinCMoullecGBaconSLLavoieKLImpact of anxiety and depression on chronic obstructive pulmonary disease exacerbation riskAm J Respir Crit Care Med2012185991892322246177
   PubMed Web of Science ®Google Scholar
• HallinRKoivisto-HurstiUKLindbergEJansonCNutritional status, dietary energy intake and the risk of exacerbations in patients with chronic obstructive pulmonary disease (COPD)Respir Med2006100356156716019198
   PubMed Web of Science ®Google Scholar
• CorhayJLVinckenWSchlesserMBossuytPImschootJChronic bronchitis in COPD patients is associated with increased risk of exacerbations: a cross-sectional multicentre studyInt J Clin Pract201367121294130124246208
   PubMed Web of Science ®Google Scholar
• NielsenRKlemmetsbyMGulsvikAEconomics of COPD: literature review and experiences from field workClin Respir J20082suppl 110411020298358
   PubMed Web of Science ®Google Scholar
• JohannessenAOmenaasERBakkePSGulsvikAImplications of reversibility testing on prevalence and risk factors for chronic obstructive pulmonary disease: a community studyThorax2005601084284716085729
   PubMed Web of Science ®Google Scholar
• LamprechtBMcBurnieMAVollmerWMBOLD Collaborative Research GroupCOPD in never smokers: results from the population-based burden of obstructive lung disease studyChest2011139475276320884729
   PubMed Web of Science ®Google Scholar
• GulsvikATostesonTBakkePHumerfeltSWeissSTSpeizerFEExpiratory and inspiratory forced vital capacity and one-second forced volume in asymptomatic never-smokers in NorwayClin Physiol200121664866011722472
   PubMedGoogle Scholar
• ATSStandardization of spirometryAm J Respir Crit Care Med1995199515211071136
   Google Scholar
• LandisSHMuellerovaHManninoDMContinuing to Confront COPD International Patient Survey: methods, COPD prevalence, and disease burden in 2012–2013Int J Chron Obstruct Pulmon Dis2014959761124944511
   PubMed Web of Science ®Google Scholar
• JanssonSABackmanHStenlingALindbergARönmarkELundbäckBHealth economic costs of COPD in Sweden by disease severity – has it changed during a ten years period?Respir Med2013107121931193823910072
   PubMed Web of Science ®Google Scholar
• CharlsonMEPompeiPAlesKLMacKenzieCRA new method of classifying prognostic comorbidity in longitudinal studies: development and validationJ Chronic Dis19874053733833558716
   PubMedGoogle Scholar
• AnthonisenNRManfredaJWarrenCPHershfieldESHardingGKNelsonNAAntibiotic therapy in exacerbations of chronic obstructive pulmonary diseaseAnn Intern Med198710621962043492164
   PubMed Web of Science ®Google Scholar
• DonaldsonGCWedzichaJACOPD exacerbations. 1: epidemiologyThorax200661216416816443707
   PubMed Web of Science ®Google Scholar
• KeeneONCalverleyPMJonesPWVestboJAndersonJAStatistical analysis of exacerbation rates in COPD: TRISTAN and ISOLDE revisitedEur Respir J2008321172418591336
   PubMed Web of Science ®Google Scholar
• SpencerSCalverleyPMBurgePSJonesPWImpact of preventing exacerbations on deterioration of health status in COPDEur Respir J200423569870215176682
   PubMed Web of Science ®Google Scholar
• CampPGGoringSMGender and the diagnosis, management, and surveillance of chronic obstructive pulmonary diseaseProc Am Thorac Soc20074868669118073404
   PubMedGoogle Scholar
• AryalSDiaz-GuzmanEManninoDMCOPD and gender differences: an updateTransl Res2013162420821823684710
   PubMed Web of Science ®Google Scholar
• BecklakeMRKauffmannFGender differences in airway behaviour over the human life spanThorax199954121119113810567633
   PubMed Web of Science ®Google Scholar
• KilicHKokturkNSariGCakırMDo females behave differently in COPD exacerbation?Int J Chron Obstruct Pulmon Dis20151082383025977604
   PubMed Web of Science ®Google Scholar
• VarkeyJBVarkeyABVarkeyBProphylactic vaccinations in chronic obstructive pulmonary disease: current statusCurr Opin Pulm Med2009152909919532022
   PubMed Web of Science ®Google Scholar
• EvansCCrawfordBPatient self-reports in pharmacoeconomic studies. Their use and impact on study validityPharmacoeconomics199915324125610537432
   PubMed Web of Science ®Google Scholar
• NielsenRCosts of Chronic Obstructive Pulmonary Disease in a General PopulationMethodological Aspects and Longitudinal Perspectives (dissertation)BergenUniversity of Bergen2011
   Google Scholar
• NielsenRJohannessenAOmenaasERBakkePSAskildsenJEGulsvikAExcessive costs of COPD in ever-smokers. A longitudinal community studyRespir Med2011105348549321030232
   PubMed Web of Science ®Google Scholar
• ErdalMJohannessenAAskildsenJEEaganTGulsvikAGrønsethRProductivity losses in chronic obstructive pulmonary disease: a population-based surveyBMJ Open Respir Res201411e000049
   PubMedGoogle Scholar